[go: up one dir, main page]

AU6679300A - Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto - Google Patents

Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto

Info

Publication number
AU6679300A
AU6679300A AU66793/00A AU6679300A AU6679300A AU 6679300 A AU6679300 A AU 6679300A AU 66793/00 A AU66793/00 A AU 66793/00A AU 6679300 A AU6679300 A AU 6679300A AU 6679300 A AU6679300 A AU 6679300A
Authority
AU
Australia
Prior art keywords
methods
pharmaceutical compositions
compositions relating
charged dextran
mucoactive agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66793/00A
Inventor
Malcolm King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
University of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alberta filed Critical University of Alberta
Publication of AU6679300A publication Critical patent/AU6679300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU66793/00A 1999-08-26 2000-08-25 Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto Abandoned AU6679300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15060599P 1999-08-26 1999-08-26
US60150605 1999-08-26
PCT/CA2000/000989 WO2001015672A2 (en) 1999-08-26 2000-08-25 Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto

Publications (1)

Publication Number Publication Date
AU6679300A true AU6679300A (en) 2001-03-26

Family

ID=22535267

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66793/00A Abandoned AU6679300A (en) 1999-08-26 2000-08-25 Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto

Country Status (5)

Country Link
EP (1) EP1212047A2 (en)
AU (1) AU6679300A (en)
CA (1) CA2382259A1 (en)
HK (1) HK1047246A1 (en)
WO (1) WO2001015672A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534075A (en) * 2001-06-14 2004-11-11 ノボ　ノルディスク　アクティーゼルスカブ Mucosal repair with TFF dimer peptide
AU2003245794A1 (en) * 2002-02-18 2003-09-04 University Of Southampton Glycosaminoglycan-dnase combination therapy
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
GB2430881B (en) 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
CN107050047B (en) 2007-11-27 2021-06-11 阿尔吉法玛公司 Sterile aqueous or sterile oil debridement compositions and products containing combined preparations
US8691286B2 (en) * 2009-01-27 2014-04-08 Teleflex Medical Incorporated Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
PT2437783E (en) 2009-06-03 2014-01-22 Algipharma As Treatment of acinetobacter with alginate oligomers and antibiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015216A1 (en) * 1990-04-05 1991-10-17 Kennedy Thomas P Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans

Also Published As

Publication number Publication date
WO2001015672A3 (en) 2002-02-28
WO2001015672A2 (en) 2001-03-08
EP1212047A2 (en) 2002-06-12
CA2382259A1 (en) 2001-03-08
HK1047246A1 (en) 2003-02-14

Similar Documents

Publication Publication Date Title
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2609901A (en) Antimicrobial compositions and methods of use
HUP0203971A3 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use
AU2319100A (en) Amide derivatives and drug compositions
AU3216600A (en) Analgesic compositions comprising anti-epileptic compounds and methods of using same
AU7389300A (en) Methods of administration of glycopyrrolate compositions
IL148168A0 (en) Pharmaceutical composition of nateglinide and another antidiabetic agent
HUP0202654A3 (en) Pharmaceutical compositions of fibrinolytic agent and process for preparation thereof
AU5565099A (en) Pharmaceutical compositions and methods for use
WO2001041823A8 (en) Radioactive compositions and methods of use thereof
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU1164601A (en) Therapeutic use and formulation
AU2003260241A1 (en) Buguzhi agent and composition and methods of preparing and administering the same
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU2575201A (en) Use of hsp27 as an anti-inflammatory agent
AU7651100A (en) Pharmaceutical and/or cosmetical compositions
AU6679300A (en) Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
AU1152601A (en) Compositions and their use
AU3774100A (en) Heat-activated cleaning compositions with wrinkle-resistance and methods of use
AU2962400A (en) Cleaner composition and method of use thereof
AU6094200A (en) Nor gene compositions and methods for use thereof
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase